SHZ · Financial Statements

HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) Financial Statements

$2.95 SHZ: 002437.SZ Market Cap $8.99B

Full income statement, balance sheet, and cash flow statement for HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio0.37
EV / EBITDA25.03
FCF Yield—
Quick Ratio1.57
Interest Coverage—
Return 1Y-6.92%
Return 3Y21.81%
Return 5Y26.50%

HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) financials — frequently asked questions

What is 002437.SZ EV/EBITDA?

HARBIN GLORIA PHARMACEUTICALS Co., LTD's enterprise value to EBITDA (EV/EBITDA) ratio is 25.03.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
002437.SZ Overview 002437.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.